Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Cano

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Chest|August 11, 2004
C-reactive protein and body mass index predict outcome in end-stage respiratory failureNoël J M Cano, Claude Pichard, Hubert Roth, et al.
The European Respiratory Journal|August 9, 2002
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilationN J M Cano, H Roth, I Court-Ortuné, et al.
The British Journal of Nutrition|January 31, 2006
Intradialytic parenteral nutrition: comparison of olive oil versus soybean oil-based lipid emulsionsNoël J M Cano, Yannick Saingra, Anne-Marie Dupuy, et al.
Scientific Reports|May 20, 2022
Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variantsB Benito-Sánchez, A Barroso, V Fernández, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|September 1, 1986
[Colorectal endoscopic polypectomies performed during 1 year]E Garza Trasobares, J M Suárez de Parga, P Mora Sanz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2015
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance statusP Pérez-Segura, R Manneh, I Ceballos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 25, 2013
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in SpainC Balañá, M A Vaz, D Lopez, et al.
The Oncologist|June 15, 2026
Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?J López-Robles, M Mitjavila, P Jimenez-Fonseca, et al.
ESMO Open|June 17, 2022
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registryJ Gallego Plazas, A Arias-Martinez, A Lecumberri, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 7, 2019
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registryA Viúdez, A Carmona-Bayonas, J Gallego, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Chest|August 11, 2004
C-reactive protein and body mass index predict outcome in end-stage respiratory failureNoël J M Cano, Claude Pichard, Hubert Roth, et al.
The European Respiratory Journal|August 9, 2002
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilationN J M Cano, H Roth, I Court-Ortuné, et al.
The British Journal of Nutrition|January 31, 2006
Intradialytic parenteral nutrition: comparison of olive oil versus soybean oil-based lipid emulsionsNoël J M Cano, Yannick Saingra, Anne-Marie Dupuy, et al.
Scientific Reports|May 20, 2022
Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variantsB Benito-Sánchez, A Barroso, V Fernández, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|September 1, 1986
[Colorectal endoscopic polypectomies performed during 1 year]E Garza Trasobares, J M Suárez de Parga, P Mora Sanz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2015
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance statusP Pérez-Segura, R Manneh, I Ceballos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 25, 2013
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in SpainC Balañá, M A Vaz, D Lopez, et al.
The Oncologist|June 15, 2026
Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?J López-Robles, M Mitjavila, P Jimenez-Fonseca, et al.
ESMO Open|June 17, 2022
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registryJ Gallego Plazas, A Arias-Martinez, A Lecumberri, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 7, 2019
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registryA Viúdez, A Carmona-Bayonas, J Gallego, et al.
Pageof 12